Tender detail
Open-house pharmaceutical rebate agreements for medicines containing indacaterol, glycopyrronium bromide and mometasone
Summary
The procurement covers non-exclusive pharmaceutical rebate agreements for medicines containing indacaterol, glycopyrronium bromide and mometasone (ATC R03AL12). Agreements may be concluded at any time under the open-house model and cover the period from 1 December 2026 to 30 November 2028. Medicines included on the BfArM list of paediatric medicines are excluded.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.